NCI Explores AI’s Potential for Cancer Screenings
Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, NCI
The National Cancer Institute (NCI) is exploring how it can leverage artificial intelligence to enhance cancer screening techniques, ultimately improving patient outcomes across the nation.
Dr. Katrina Goddard, director of the Division of Cancer Control and Population Sciences at NCI, explains how her division is leveraging AI, and other innovative solutions like the low-dose CT scan, to better detect lung cancer and enable better access to data.
Goddard also shares details from a recent study that highlighted the major role screenings and prevention have played in decreasing the cancer mortality rates over the past 40 years.
-
Dr. Katrina Goddard Director, Division of Cancer Control and Population Sciences, NCI
-
Driving Mission Impact with Scalable AI
IT leaders explore AI innovation, development and integration into cloud environments to drive operational excellence.
33m watch -
NCI's Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
A new tech-based therapy is helping NCI treat patients who suffer from a respiratory illness associated with HPV.
23m listen -
Opinion: America's Reindustrialization Must Be AI-Driven
The future of American industry built by artificial intelligence drives a need to upskill the workforce and leverage tariffs carefully.
4m read -
Contact with the Enemy Drives Tech Innovation, Army Officials Say
U.S. Army leaders are testing technology on the battlefield to drive innovation as the service pursues its 2030 modernization goals.
5m read
